Evidence map›Paper›PMID 18276010›Full record

ArticleMolecular immunology2008

Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling.

Eddie A James, Antonis K Moustakas, Deanna Berger, Laurie Huston, George K Papadopoulos, William W Kwok

Abstract read
In one paragraph

Article in Molecular immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eddie A JamesBenaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA.
Antonis K Moustakas
Deanna Berger
Laurie Huston
George K Papadopoulos
William W Kwok

Funding

NIAID NIH HHS HHSN266200400028C
6 · The paper itself

Abstract

This study identified the peptide-binding motif of HLA-DRA/DRB1*1401 (DR1401). First, peptides containing DR1401 restricted epitopes were identified using tetramer-guided epitope mapping. Among these, an influenza B peptide was selected for the motif study. After confirming the binding register for this peptide using a set of arginine substitutions, binding affinities were determined for 33 peptides derived from this influenza B sequence with single amino acid substitutions. The DR1401 peptide-binding motif was deduced from the relative binding affinities of these peptides and confirmed by structural modeling. Pocket 1 demonstrated a preference for aliphatic anchor residues and methionine. Pocket 4 accommodated methionine and aliphatic residues, but also allowed some polar and charged amino acids. Pocket 6 preferred basic residues but also allowed some polar and aliphatic amino acids. Pocket 9 preferred aliphatic and aromatic amino acids and tolerated some polar residues but excluded all charged residues. Together these preferences define a distinct set of peptides that can be presented by DR1401. The resulting motif was used to verify T cell epitopes within the novel antigenic peptides identified by tetramer-guided epitope mapping and within peptides from published reports that contain putative DR1401 epitopes.

Indexed as

Amino Acid MotifsAmino Acid SubstitutionBinding SitesEpitope MappingEpitopes, T-LymphocyteHemagglutinin Glycoproteins, Influenza VirusHLA-DR AntigensHLA-DRB1 ChainsHumansInfluenza B virusModels, MolecularPeptidesProtein BindingRecombinant ProteinsStructure-Activity RelationshipT-LymphocytesEpitopes, T-LymphocyteHemagglutinin Glycoproteins, Influenza VirusHLA-DR AntigensHLA-DRB1 ChainsPeptidesRecombinant Proteins

Identifiers

PMID18276010
PMCPMC2785711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.